Insight into inclusion complexation of indomethacin nicotinamide cocrystals

This publication has 23 references indexed in Scilit:

• Recent advances in crystal engineering
  CrystEngComm, 2009
• Organometallic cavitands: Cation–π interactions and anion binding via π-metallation
  Coordination Chemistry Reviews, 2007
• Cyclodextrins as pharmaceutical solubilizers
  Advanced Drug Delivery Reviews, 2007
• Cocrystal or Salt: Does It Really Matter?
  Molecular Pharmaceutics, 2007
• Reaction Crystallization of Pharmaceutical Molecular Complexes
  Molecular Pharmaceutics, 2006
• Lanthanide-induced helical arrays of [{Co( iii ) sepulchrate} ∩ {p-sulfonatocalix[4]arene}] supermolecules
  Chemical Communications, 2005
• Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines?
  Chemical Communications, 2004
• Crystal structures of drugs: advances in determination, prediction and engineering
  Nature Reviews Drug Discovery, 2004
• Mechanochemistry and co-crystal formation: effect of solvent on reaction kineticsElectronic supplementary information (ESI) available for PXRD profiles showing the grinding results for CTA + Bipy with and without solvent as well as CTA + 2fPh with different solvents. See http://www.rsc.org/suppdata/cc/b2/b207369m/
  Chemical Communications, 2002
• The Driving Forces in the Inclusion Complexation of Cyclodextrins
  Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2002